Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of Mpro and Its Antiviral Activity in Cells against SARS-CoV-2
Francesca Mangiavacchi, Paweł Botwina, Elena Menichetti, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7048-7048
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

The SARS‐CoV‐2 main protease (Mpro): Structure, function, and emerging therapies for COVID‐19
Qing Hu, Yuan Xiong, Guanghao Zhu, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 144
Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PLpro and Mpro proteases, and nsp14 guanine N7-methyltransferase
Mikołaj Żmudziński, Wioletta Rut, Kamila Olech, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives
Andrea Citarella, Alessandro Dimasi, Davide Moi, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1339-1339
Open Access | Times Cited: 22
“Green Is the Color”: An Update on Ecofriendly Aspects of Organoselenium Chemistry
Juliano B. Azeredo, Filipe Penteado, Vanessa Nascimento, et al.
Molecules (2022) Vol. 27, Iss. 5, pp. 1597-1597
Open Access | Times Cited: 36
Isoquercetin as an Anti-Covid-19 Medication: A Potential to Realize
Majambu Mbikay, Michel Chrètien
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29
Recent Advances in Light-Induced Selenylation
Stefano Protti, Maurizio Fagnoni
ACS Organic & Inorganic Au (2022) Vol. 2, Iss. 6, pp. 455-463
Open Access | Times Cited: 29
A Comprehensive Review of Natural Flavonoids with Anti-SARS-CoV-2 Activity
Junyu Yang, Yixuan Ma, Yan Liu, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2735-2735
Open Access | Times Cited: 19
Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors
Letian Song, Shenghua Gao, Bing Ye, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 87-109
Open Access | Times Cited: 19
Therapeutic implications of quercetin and its derived-products in COVID-19 protection and prophylactic
Wan‐Yi Ho, Zi-han Shen, Yijing Chen, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30080-e30080
Open Access | Times Cited: 5
Insights into SARS-CoV-2 structure: Approaches and action of SARS-CoV-2 main protease inhibitor
Ilma Shakeel, Aaliya Taiyab, Aanchal Rathi, et al.
Elsevier eBooks (2025), pp. 89-117
Closed Access
The emerging role of miRNAs in the pathogenesis of COVID-19: Protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection
Chih-Yun Yang, Yu‐Hsuan Chen, Pei-Jung Liu, et al.
International Journal of Medical Sciences (2022) Vol. 19, Iss. 8, pp. 1340-1356
Open Access | Times Cited: 22
Anti-SARS-CoV-2, antioxidant and immunomodulatory potential of dietary flavonol quercetin: Focus on molecular targets and clinical efficacy
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, et al.
European Journal of Medicinal Chemistry Reports (2023) Vol. 10, pp. 100125-100125
Open Access | Times Cited: 14
Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitors
Nora Astrain-Redín, Niccolò Paoletti, Daniel Plano, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 13
Development of Fluorescence-Based Assays for Key Viral Proteins in the SARS-CoV-2 Infection Process and Lifecycle
Mingzhenlong Deng, Chuang Zhang, Wanli Yan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2850-2850
Open Access | Times Cited: 4
Trichloroisocyanuric Acid (TCCA): A Suitable Reagent for the Synthesis of Selanyl‐benzo[b]chalcogenophenes
Gustavo B. Blödorn, Luis Fernando B. Duarte, Juliano A. Roehrs, et al.
European Journal of Organic Chemistry (2022) Vol. 2022, Iss. 40
Closed Access | Times Cited: 18
Recent Advances on SARS-CoV-2 Mpro Inhibitors: From Nirmatrelvir to Future Perspectives
Andrea Citarella, Alessandro Dimasi, Davide Moi, et al.
(2023)
Open Access | Times Cited: 11
Ecofriendly aminochalcogenation of alkenes: a green alternative to obtain compounds with potential anti-SARS-CoV-2 activity
Luana da Silva Gomes, José S. S. Neto, Iris Di Leo, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 14, pp. 6591-6601
Closed Access | Times Cited: 10
Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds
Bruno Rizzuti, Laura Ceballos-Laita, David Ortega-Alarcón, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 892-892
Open Access | Times Cited: 23
Effective and Selective Extraction of Quercetin from Onion (Allium cepa L.) Skin Waste Using Water Dilutions of Acid-Based Deep Eutectic Solvents
Matteo Ciardi, Federica Ianni, Roccaldo Sardella, et al.
Materials (2021) Vol. 14, Iss. 21, pp. 6465-6465
Open Access | Times Cited: 23
A Review of Different Vaccines and Strategies to Combat COVID-19
S. Sabitha, Nagarajan Shobana, Pandurangan Prakash, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 737-737
Open Access | Times Cited: 17
Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 6, pp. 100079-100079
Open Access | Times Cited: 17
Antiviral Effect of 5′-Arylchalcogeno-3-aminothymidine Derivatives in SARS-CoV-2 Infection
Amanda Resende Tucci, Raquel Mello da Rosa, Alice Santos Rosa, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6696-6696
Open Access | Times Cited: 8
Effect and mechanism of quercetin or quercetin‐containing formulas against COVID‐19: From bench to bedside
Jhong Yuan Chen, Tsung Rung Huang, Shih Yun Hsu, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2597-2618
Closed Access | Times Cited: 2
Iodine/Oxone® oxidative system for the Synthesis of Selenylindoles Bearing Benzenesulfonamide Moiety as Carbonic Anhydrase I, II, IX, and XII Inhibitors
Martina Palomba, Andrea Angeli, Riccardo Galdini, et al.
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 32, pp. 6532-6542
Open Access | Times Cited: 2
Comparative evaluation of flavonoids reveals the superiority and promising inhibition activity of silibinin against SARS‐CoV‐2
Rania Hamdy, Ahmed Mostafa, Noura M. Abo Shama, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 7, pp. 2921-2939
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top